|
1.
|
Holm T, Cedermark B and Rutqvist LE: Local
recurrence of rectal adenocarcinoma after ‘curative’ surgery with
and without pre-operative radiotherapy. Br J Surg. 81:452–455.
1994.
|
|
2.
|
Sauer R, Becker H, Hohenberger W, Rödel C,
Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF,
Karstens JH, Liersch T, Schmidberger H and Raab R; German Rectal
Cancer Study Group: Pre-operative versus postoperative
chemoradiotherapy for rectal cancer. N Engl J Med. 351:1731–1740.
2004.
|
|
3.
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004.
|
|
4.
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005.
|
|
5.
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005.
|
|
6.
|
Miranda KC, Huynh T, Tay Y, Ang YS, Tam
WL, Thomson AM, Lim B and Rigoutsos I: A pattern-based method for
the identification of microRNA binding sites and their
corresponding heteroduplexes. Cell. 126:1203–1217. 2006.
|
|
7.
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006.
|
|
8.
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006.
|
|
9.
|
Johnson CD, Esquela-Kerscher A, Stefani G,
Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J,
Shingara J, Chin L, Brown D and Slack FJ: The let-7 micro-RNA
represses cell proliferation pathways in human cells. Cancer Res.
67:7713–7722. 2007.
|
|
10.
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005.
|
|
11.
|
Jay C, Nemunaitis J, Chen P, Fulgham P and
Tong AW: miRNA profiling for diagnosis and prognosis of human
cancer. DNA Cell Biol. 26:293–300. 2007.
|
|
12.
|
Yu SL, Chen HY, Yang PC and Chen JJ:
Unique microRNA signature and clinical outcome of cancers. DNA Cell
Biol. 26:283–292. 2007.
|
|
13.
|
Japanese Society for Cancer of the Colon
and Rectum: Response Assessment of Nonsurgical Treatment for
Colorectal Carcinoma. Japanese classification of colorectal
carcinoma. 1st English edition. Kanehara & Co. Ltd.; Tokyo: pp.
77–82. 1997
|
|
14.
|
Aslam MI, Taylor K, Pringle JH and Jameson
JS: MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg.
96:702–710. 2009.
|
|
15.
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M,
Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M,
Harris CC and Croce CM: A microRNA expression signature of human
solid tumors defines cancer gene targets. Proc Natl Acad Sci USA.
103:2257–2261. 2006.
|
|
16.
|
Monzo M, Navarro A, Bandres E, Artells R,
Moreno I, Gel B, Ibeas R, Moreno J, Martinez F, Diaz T, Martinez A,
Balagué O and Garcia-Foncillas J: Overlapping expression of
microRNAs in human embryonic colon and colorectal cancer. Cell Res.
18:823–833. 2008.
|
|
17.
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu
CG, Calin GA, Croce CM and Harris CC: MicroRNA expression profiles
associated with prognosis and therapeutic outcome in colon
adenocarcinoma. JAMA. 299:425–436. 2008.
|
|
18.
|
Svoboda M, Izakovicova Holla L, Sefr R,
Vrtkova I, Kocakova I, Tichy B and Dvorak J: Micro-RNAs miR125b and
miR137 are frequently upregulated in response to capecitabine
chemoradiotherapy of rectal cancer. Int J Oncol. 33:541–547.
2008.
|
|
19.
|
Weidhaas JB, Babar I, Nallur SM, Trang P,
Roush S, Boehm M, Gillespie E and Slack FJ: MicroRNAs as potential
agents to alter resistance to cytotoxic anticancer therapy. Cancer
Res. 67:11111–11116. 2007.
|
|
20.
|
Josson S, Sung SY, Lao K, Chung LW and
Johnstone PA: Radiation modulation of microRNA in prostate cancer
cell lines. Prostate. 68:1599–1606. 2008.
|
|
21.
|
Sorrentino A, Liu CG, Addario A, Peschle
C, Scambia G and Ferlini C: Role of microRNAs in drug-resistant
ovarian cancer cells. Gynecol Oncol. 111:478–486. 2008.
|
|
22.
|
Salter KH, Acharya CR, Walters KS, Redman
R, Anguiano A, Garman KS, Anders CK, Mukherjee S, Dressman HK,
Barry WT, Marcom KP, Olson J, Nevins JR and Potti A: An integrated
approach to the prediction of chemotherapeutic response in patients
with breast cancer. PLoS One. 3:e19082008.
|
|
23.
|
Nakajima G, Hayashi K, Xi Y, Kudo K,
Uchida K, Takasaki K, Yamamoto M and Ju J: Non-coding microRNAs
hsa-let-7g and hsa-miR-181b are associated with chemoresponse to
S-1 in colon cancer. Cancer Genom Proteom. 3:317–324. 2006.
|
|
24.
|
Fazi F, Rosa A, Fatica A, Gelmetti V, De
Marchis ML, Nervi C and Bozzoni I: A minicircuitry comprised of
microRNA-223 and transcription factors NFI-A and C/EBPalpha
regulates human granulopoiesis. Cell. 23:819–831. 2005.
|
|
25.
|
Sugatani T and Hruska KA: MicroRNA-223 is
a key factor in osteoclast differentiation. J Cell Biochem.
101:996–999. 2007.
|
|
26.
|
Fukao T, Fukuda Y, Kiga K, Sharif J, Hino
K, Enomoto Y, Kawamura A, Nakamura K, Takeuchi T and Tanabe M: An
evolutionarily conserved mechanism for microRNA-223 expression
revealed by microRNA gene profiling. Cell. 129:617–631. 2007.
|
|
27.
|
Wong QW, Lung RW, Law PT, Lai PB, Chan KY,
To KF and Wong N: MicroRNA-223 is commonly repressed in
hepatocellular carcinoma and potentiates expression of
Stathmin1. Gastroenterology. 135:257–269. 2008.
|
|
28.
|
Melhem RF, Strahler JR, Hailat N, Zhu XX
and Hanash SM: Involvement of OP18 in cell proliferation. Biochem
Biophys Res Commun. 179:1649–1655. 1991.
|
|
29.
|
Rubin CL and Atweh GF: The role of
stathmin in the regulation of the cell cycle. J Cell Biochem.
93:242–250. 2004.
|
|
30.
|
Brattsand G, Roos G, Marklund U, Ueda H,
Landberg G, Nånberg E, Sideras P and Gullberg M: Quantitative
analysis of the expression and regulation of an
activation-regulated phosphoprotein (oncoprotein 18) in healthy and
neoplastic cells. Leukemia. 7:569–579. 1993.
|
|
31.
|
Ghosh R, Gu G, Tillman E, Yuan J, Wang Y,
Fazli L, Rennie PS and Kasper S: Increased expression and
differential phosphorylation of stathmin may promote prostate
cancer progression. Prostate. 67:1038–1052. 2007.
|
|
32.
|
Alli E, Yang JM, Ford JM and Hait WN:
Reversal of stathmin-mediated resistance to paclitaxel and
vinblastine in human breast carcinoma cells. Mol Pharmacol.
71:1233–1240. 2007.
|
|
33.
|
Saal LH, Johansson P, Holm K,
Gruvberger-Saal SK, She QB, Maurer M, Koujak S, Ferrando AA,
Malmström P, Memeo L, Isola J, Bendahl PO, Rosen N, Hibshoosh H,
Ringnér M, Borg A and Parsons R: Poor prognosis in carcinoma is
associated with a gene expression signature of aberrant PTEN tumor
suppressor pathway activity. Proc Natl Acad Sci USA. 104:7564–7569.
2007.
|
|
34.
|
Johnnidis JB, Harris MH, Wheeler RT,
Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD and
Camargo FD: Regulation of progenitor cell proliferation and
granulocyte function by microRNA-223. Nature. 451:1125–1129.
2008.
|
|
35.
|
Guo R, Wu Q, Liu F and Wang Y: Description
of the CD133+ subpopulation of the human ovarian cancer
cell line OVCAR3. Oncol Rep. 25:141–146. 2011.
|
